Pancreatic Cancer Research

ResearcherLeiden University Medical CenterNo recent work listed

Cornelis F.M. Sier

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4337-2758; OpenAlex author ID A5020233877. Sources: OpenAlex.

Their work

Papers
8 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
25
Papers, trials and grants by year

2016: 1 paper · 2017: 2 papers · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: 2 papers · 2022: none · 2023: 1 paper

Papers 8

  1. Prediction of Biomarker Expression on Primary Pancreatic Ductal Adenocarcinoma Tissues Using Fine-Needle Biopsies: Paving the Way for a Patient-Tailored Molecu… Co-author DOI 10.1007/s40291-022-00635-w↗
  2. An Immunohistochemical Evaluation of Tumor-Associated Glycans and Mucins as Targets for Molecular Imaging of Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3390/cancers13225777↗
  3. Overview and Future Perspectives on Tumor-Targeted Positron Emission Tomography and Fluorescence Imaging of Pancreatic Cancer in the Era of Neoadjuvant Therapy. Co-author DOI 10.3390/cancers13236088↗
  4. Molecular targets for diagnostic and intraoperative imaging of pancreatic ductal adenocarcinoma after neoadjuvant FOLFIRINOX treatment. Co-author DOI 10.1038/s41598-020-73242-6↗
  5. ITGA5 inhibition in pancreatic stellate cells attenuates desmoplasia and potentiates efficacy of chemotherapy in pancreatic cancer. Co-author DOI 10.1126/sciadv.aax2770↗
  6. Prognostic Impact of Urokinase Plasminogen Activator Receptor Expression in Pancreatic Cancer: Malignant Versus Stromal Cells. Last author DOI 10.1177/1177271917715443↗
  7. Selection of optimal molecular targets for tumor-specific imaging in pancreatic ductal adenocarcinoma. Co-author DOI 10.18632/oncotarget.18232↗
  8. Selecting Tumor-Specific Molecular Targets in Pancreatic Adenocarcinoma: Paving the Way for Image-Guided Pancreatic Surgery. Co-author DOI 10.1007/s11307-016-0959-4↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Peter J.K. Kuppen · 8 shared papers, 2016–2023 · strength 0.74
  2. Alexander L. Vahrmeijer · 8 shared papers, 2016–2023 · strength 0.74
  3. Bert A. Bonsing · 7 shared papers, 2016–2023 · strength 0.66
  4. J. Sven D. Mieog · 6 shared papers, 2016–2023 · strength 0.60
  5. Ruben D. Houvast · 3 shared papers, 2021–2023 · strength 0.39
  6. Rutger‐Jan Swijnenburg · 4 shared papers, 2016–2021 · strength 0.32
  7. Floris A. Vuijk · 2 shared papers, 2020–2021 · strength 0.20
  8. Susanna W.L. de Geus · 3 shared papers, 2016–2019 · strength 0.20
  9. Jeanin Elise van Hooft · 1 shared paper, 2023 · strength 0.16
  10. Jesse V. Groen · 1 shared paper, 2021 · strength 0.12
  11. Hans Morreau · 2 shared papers, 2016–2017 · strength 0.12
  12. Willemieke S. F. J. Tummers · 2 shared papers, 2016–2017 · strength 0.11
  13. Martijn A. van Dam · 1 shared paper, 2021 · strength 0.11
  14. Johanna W. Wilmink · 1 shared paper, 2020 · strength 0.09
  15. Lysanne D. A. N. de Muynck · 1 shared paper, 2020 · strength 0.09
  16. Joanne Verheij · 1 shared paper, 2020 · strength 0.09
  17. Marc G. Besselink · 1 shared paper, 2020 · strength 0.09
  18. Jonas Schnittert · 1 shared paper, 2019 · strength 0.08
  19. Praneeth Reddy Kuninty · 1 shared paper, 2019 · strength 0.08
  20. Deby Fajar Mardhian · 1 shared paper, 2019 · strength 0.08
  21. Hanneke W.M. van Laarhoven · 1 shared paper, 2019 · strength 0.08
  22. Arne Östman · 1 shared paper, 2019 · strength 0.08
  23. Jai Prakash · 1 shared paper, 2019 · strength 0.08
  24. Maarten F. Bijlsma · 1 shared paper, 2019 · strength 0.08
  25. Casper H.J. van Eijck · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.